| Issue Date | Title | Author(s) |
| 2021-09 | Therapeutic targets in lung tissue remodelling and fibrosis. | Liu, G; Philp, AM; Corte, T; Travis, MA; Schilter, H; Hansbro, NG; Burns, CJ; Eapen, MS; Sohal, SS; Burgess, JK; Hansbro, PM |
| 2021-09-21 | Exposure to the gut microbiota from cigarette smoke-exposed mice exacerbates cigarette smoke extract-induced inflammation in zebrafish larvae | Morris, S; Wright, K; Malyla, V; Britton, WJ; Hansbro, PM; Cholan, PM; Oehlers, SH |
| 2021-01-01 | Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease | Blomme, EE; Provoost, S; De Smet, EG; De Grove, KC; Van Eeckhoutte, HP; De Volder, J; Hansbro, PM; Bonato, M; Saetta, M; Wijnant, SRA; Verhamme, F; Joos, GF; Bracke, KR; Brusselle, GG; Maes, T |
| 2019-08-01 | Inhibition of mast cells with a Siglec-8 antibody reduces tissue damage in models of skin and lung fibrosis and COPD | Youngblood, BA; Falahati, R; Leung, J; Brock, EC; Hansbro, PM; Tomasevic, N |
| 2020-10-26 | Differences in pulmonary innate lymphoid cells are dependent on mouse age, sex and strain | Loering, S; Cameron, GJM; Bhatt, NP; Belz, GT; Foster, PS; Hansbro, PM; Starkey, MR |
| 2021-10 | Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease. | Skerrett-Byrne, DA; Bromfield, EG; Murray, HC; Jamaluddin, MFB; Jarnicki, AG; Fricker, M; Essilfie, AT; Jones, B; Haw, TJ; Hampsey, D; Anderson, AL; Nixon, B; Scott, RJ; Wark, PAB; Dun, MD; Hansbro, PM |
| 2021-09-17 | Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. | Christie, MJ; Irving, AT; Forster, SC; Marsland, BJ; Hansbro, PM; Hertzog, PJ; Nold-Petry, CA; Nold, MF |
| 2021-08-10 | Bisphosphonate drugs have actions outside the skeleton and inhibit the mevalonate pathway in alveolar macrophages | Munoz, MA; Fletcher, EK; Skinner, OP; Jurczyluk, J; Kristianto, E; Hodson, MP; Sun, S; Ebetino, FH; Croucher, DR; Hansbro, PM; Center, JR; Rogers, MJ |
| 2022-01 | Clinical features and mechanistic insights into drug repurposing for combating COVID-19. | Asrani, P; Tiwari, K; Eapen, MS; McAlinden, KD; Haug, G; Johansen, MD; Hansbro, PM; Flanagan, KL; Hassan, MI; Sohal, SS |
| 2021-11 | COPD exacerbations: targeting IL-33 as a new therapy. | Kim, RY; Oliver, BG; Wark, PAB; Hansbro, PM; Donovan, C |
